ENDRA Life Sciences Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
92.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.10
|
-1.00
|
0.10
|
9.09%
|
|
2022-06-30
|
-1.10
|
-1.20
|
-0.10
|
-9.09%
|
|
2022-03-31
|
-1.50
|
-1.40
|
0.10
|
6.67%
|
|
2021-12-31
|
-1.60
|
-1.60
|
0.00
|
0.00%
|
|
2021-09-30
|
-1.50
|
-1.20
|
0.30
|
20.00%
|
|
2021-06-30
|
-1.40
|
-1.60
|
-0.20
|
-14.29%
|
|
2021-03-31
|
-1.50
|
-1.20
|
0.30
|
20.00%
|
|
2020-12-31
|
-2.90
|
-2.00
|
0.90
|
31.03%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.60
|
|
2021-12-31
|
-5.60
|
|
2020-12-31
|
-2.64
|
|
2019-12-31
|
-2.34
|
|
2018-12-31
|
-2.26
|
|
2017-12-31
|
-1.59
|